TOI ONCOLOGY INSTITUTE INC (THE)

WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio

WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio

CERRITOS, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- WellBe Senior Medical announced today that it is strengthening its cancer care capabilities to further support its mission of managing the population health of polychronic Medicare Advantage patients by partnering with leading cancer care provider, The Oncology Institute, Inc. (NASDAQ: TOI).

WellBe now offers The Oncology Institute’s High-Value Cancer Care Program to eligible patients in Illinois and Ohio. As part of this program, TOI provides care management and supportive care services customized to the needs of the individual patient with active cancer diagnoses. This program has demonstrated significant improvements in patient satisfaction, less acute care facility utilization, and is focused on addressing the supportive care needs of patients without displacing the community oncologist.

“At WellBe, we partner with health plans to care for their most complex members and bring customized care to their homes,” shared Dr. Iyad Houshan, Chief Medical Officer of WellBe Senior Medical. “A cancer diagnosis is a life-changing event for all, and especially for seniors with multiple chronic conditions. We chose The Oncology Institute to partner with so that we can offer added care and resources to our patients and their families to help mitigate some of the burdens during a cancer treatment episode.”

“We are excited about the opportunity to serve more patients in partnership with WellBe Senior Medical across these two new states for TOI,” commented Dr. Daniel Virnich, CEO of The Oncology Institute. “WellBe’s mission to provide tailored care to the frailest seniors aligns with TOI’s goals in cancer care. We have been refining this program for many years and have published outcomes that show benefit for patients. Our model ensures that we are providing complementary services to manage patient experience and acute care utilization in addition to the services that a community-based oncologist can provide.”

About The Oncology Institute

Founded in 2007, The Oncology Institute, Inc. (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit .

About WellBe Senior Care

WellBe Senior Medical works with health insurance plans to provide home-based medical care to patients who are facing multiple complex health challenges. WellBe’s healthcare experts are committed to providing personalized appointments wherever our patients call home. Our care team works together with patients, their caregivers, and physicians to nurture all aspects of health. For more information, please visit or call 1-855-477-4151.

Contacts

Investors

Solebury Strategic Communications



EN
25/01/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ONCOLOGY INSTITUTE INC (THE)

 PRESS RELEASE

The Oncology Institute Reports First Quarter 2025 Financial Results an...

The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended March 31, 2025. Recent Operational Highlights Retail Pharmacy and Dispensary set fill records, contributing $49.3 million revenue and over $9 million in gross profit in Q1. The Pharmacy and Dispensary segment grew over 20% in th...

 PRESS RELEASE

The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Off...

The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that Dr. Jeffrey Langsam will assume the role of enterprise Chief Clinical Officer effective May 13th, 2025. The CCO role will oversee therapeutics including pathway and procurement decisions, utilization management, and MSO practice clinical engagement. Dr. Langsam joins TOI from Cigna Healthcare, where he was the National Direct...

 PRESS RELEASE

The Oncology Institute to Participate at the B. Riley Securities 25th ...

The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference CERRITOS, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in B. Riley’s 25th Annual Institutional Investor Conference in Marina Del Rey, CA on May 21st, 2025. About The Oncology Institute Founded in 2007, TOI is advancing oncology by delivering...

 PRESS RELEASE

The Oncology Institute to Present at Upcoming ASCO Annual Meeting on H...

The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates CERRITOS, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI)(“TOI”), one of the largest value-based oncology groups in the United States, announced today that it has been selected to present an abstract at the upcoming ASCO Annual Meeting further validating cost savings and reduced hospitalizations associated with its unique High-Value Cancer Care (HVCC) model*. The study shares new data supporting ...

 PRESS RELEASE

The Oncology Institute Announces First Quarter 2025 Earnings Release D...

The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call CERRITOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2025 financial results after the market close on Wednesday, May 14, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers,...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch